VYNE Therapeutics to Present at the 32nd Annual Piper Sandler Healthcare Conference

BRIDGEWATER, N.J., Nov. 25, 2020 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that David Domzalski, Chief Executive Officer, will participate in a fireside chat at the virtual Piper Sandler Healthcare Conference being held December 1-3, 2020.

A recording of the fireside chat will be accessible to institutional clients of Piper Sandler beginning December 1, 2020 via Piper Sandler’s event portal. The Company will be available for institutional investor meetings on December 1, 2020.

About VYNE Therapeutics Inc.

In March 2020, Menlo Therapeutics Inc. (“Menlo”) and Foamix Pharmaceuticals Ltd. (“Foamix”) combined to form what is now known as VYNE Therapeutics Inc. VYNE’s mission is to improve the lives of patients by developing proprietary, innovative and differentiated therapies in dermatology and beyond.

With expertise in topical medicine innovation as a springboard, VYNE is working to develop and commercialize a variety of solutions using its proprietary Molecule Stabilizing Technology (MST™), and has received FDA approval for AMZEEQ® (minocycline) topical foam, 4%, the world’s first topical minocycline, and for ZILXI™ (minocycline) topical foam, 1.5%, the first minocycline product of any kind to be approved by the FDA for use in rosacea. For more information about our approved products, please see AMZEEQ’s Full Prescribing Information at AMZEEQ.com and ZILXI’s Full Prescribing Information at ZILXI.com.

For more information about VYNE Therapeutics Inc. or its investigational products, visit http://www.vynetherapeutics.com/ or follow VYNE on Twitter. VYNE may use its website to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor VYNE’s website in addition to following its press releases, filings with the U.S. Securities and Exchange Commission, public conference calls, and webcasts.

CONTACT:

Joyce Allaire
LifeSci Advisors, LLC
646-889-1200
[email protected]

Andrew Saik
Chief Financial Officer
VYNE Therapeutics
908-731-6180
[email protected]

 



uBreakiFix Grows Franchise Footprint In Texas

Electronics Repair Business Keeps Willowbrook Community Connected

HOUSTON, Nov. 25, 2020 (GLOBE NEWSWIRE) — Electronics repair shop uBreakiFix is now open in Willowbrook in northwest Houston at 7610-A Cypress Creek Parkway. The store offers repairs on smartphones, tablets, computers, and more to help the community stay connected.

“As an owner of three uBreakiFix stores, I have seen the positive impact top quality tech repair has on a community,” said Fernando Villarreal, co-owner of uBreakiFix Willowbrook. “uBreakiFix’s services are more important now than ever. A broken phone, tablet, or computer is not only inconvenient, but can inhibit connection to work, school, loved ones and more. We are eager to serve the Willowbrook community by alleviating stress with a seamless process to repair a broken device.”

uBreakiFix offers repair service on anything with a power button, from smartphones, tablets, and computers to drones, hoverboards, and game consoles. To date, uBreakiFix has completed more than 9 million repairs at more than 600 locations across North America. While common fixes include shattered screens, software issues, and camera issues, the brand offers support for most technical problems on any electronic device, regardless of make or model.

Villarreal and his business partners Jennifer and Mark Wallis also own two uBreakiFix locations in Houston with plans to open three more locations in the surrounding communities.

“At uBreakiFix, our work is meaningful because we’re able to serve people in a way that matters,” Villarreal said. “We are eager to bring this reliable tech repair service to the bustling Willowbrook community and provide a seamless process for customers with top notch customer service for all device repairs.”

uBreakiFix was founded in 2009 by millennial entrepreneurs Justin Wetherill and David Reiff to fill a gap in the market for affordable, high-quality phone repair. The duo soon partnered with Eddie Trujillo to transition their Internet-based repair brand to a brick-and-mortar model. uBreakiFix began franchising in 2013 and currently operates more than 600 locations across the U.S. and Canada.

“At uBreakiFix, our story has been shaped by an unwavering commitment to continually improving the repair experience for customers,” Wetherill said. “We founded this company to fill a need for high-quality, convenient repair with great service at a fair price. We always say we’re a customer service company first, and a tech company second. As we begin serving Willowbrook and the surrounding communities, we look forward to sharing the care and credibility that define the uBreakiFix experience.”

For more information and to view a service menu, visit ubreakifix.com/locations/willowbrook. uBreakiFix Willowbrook is located at:

uBreakiFix

7610-A Cypress Creek Pkwy, Houston, TX 77070

(346) 355-1155


About uBreakiFix


Founded in 2009, uBreakiFix specializes in the repair of small electronics, ranging from smartphones, game consoles, tablets, computers, and everything in between. Cracked screens, software issues, camera issues, and most other problems can be repaired by visiting uBreakiFix stores across the U.S. and Canada. Since 2016, uBreakiFix has served as the exclusive walk-in repair partner for Google Pixel customers. In 2018, uBreakiFix became a Samsung Care authorized service provider offering same-day, in-person support for Samsung Galaxy customers across the U.S. In 2019, uBreakiFix joined the Asurion family and now operates as a subsidiary of the tech care company while still maintaining the uBreakiFix leadership team and franchise model. For more information, visit

ubreakifix.com

.

For more information, contact:

Ellie Holt
(229) 869-5305
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5d1ec196-0794-47da-9436-7bd2a4515330



Gold Resource Corporation Declares November Monthly Dividend

COLORADO SPRINGS, Nov. 25, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Gold Resource Corporation (NYSE American: GORO) (the “Company”) declares its monthly instituted dividend of one-third of a cent per common share for November 2020 payable on December 23, 2020 to shareholders of record as of December 11, 2020.  Gold Resource Corporation is a gold and silver producer, developer and explorer with operations in Oaxaca, Mexico and Nevada, USA.  

The Company has returned $115 million to its shareholders in consecutive monthly dividends since July 2010 and offers its shareholders the option to convert their cash dividends into physical gold and silver and take delivery.  For more information on Gold Resource Corporation’s physical dividend program, visit the Company website at http://www.goldresourcecorp.com/gold-silver-dividends.php.   

Dividends may vary in amount and consistency or be discontinued at the Board of Directors’ discretion depending on variables including but not limited to operational cash flows, Company development requirements and strategies, construction, spot gold and silver prices, taxation, general market conditions and other factors described in the Cautionary Statements below and the Company’s public filings with the U.S. Securities and Exchange Commission. 

About GRC: 

Gold Resource Corporation is a gold and silver producer, developer and explorer with operations in Oaxaca, Mexico and Nevada, USA. The Company targets low capital expenditure projects with potential for generating high returns on capital. The Company has reached milestones including a decade of production, generated over $1 billion in revenue and has returned $115 million back to its shareholders in consecutive monthly dividends since July 2010. In addition, the Company also offers its shareholders the option to convert their cash dividends into physical gold and silver and take delivery. For more information, please visit GRC’s website, located at www.goldresourcecorp.com and read the Company’s 10-K for an understanding of the risk factors involved. 

Cautionary Statements:

This press release contains forward-looking statements that involve risks and uncertainties. The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. When used in this press release, the words “plan”, “target”, “anticipate,” “believe,” “estimate,” “intend” and “expect” and similar expressions are intended to identify such forward-looking statements. Such forward-looking statements include, without limitation, the statements regarding Gold Resource Corporation’s strategy, future plans for production, future expenses and costs, future liquidity and capital resources, and estimates of mineralized material. All forward-looking statements in this press release are based upon information available to Gold Resource Corporation on the date of this press release, and the company assumes no obligation to update any such forward-looking statements. Forward looking statements involve a number of risks and uncertainties, and there can be no assurance that such statements will prove to be accurate. The Company’s actual results could differ materially from those discussed in this press release. In particular, the scope, duration, and impact of the COVID-19 pandemic on mining operations, Company employees, and supply chains as well as the scope, duration and impact of government action aimed at mitigating the pandemic may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking information. Also, there can be no assurance that production will continue at any specific rate. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in the Company’s 10-K filed with the SEC. 

Contacts:

Corporate Development

Greg Patterson

303-320-7708


www.goldresourcecorp.com



Field Trip Health Ltd. Schedules Second Fiscal Quarter 2021 Financial Results Conference Call for Tuesday, December 1, 2020 at 8:00 am ET

TORONTO, Nov. 25, 2020 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (CSE: FTRP, OTCBB: FTRPF) (“Field Trip”), a global leader in the development and delivery of psychedelic therapies, announced today that it plans to release financial results for its second fiscal quarter ended September 30, 2020, after market close on Monday, November 30, 2020.

The Company will conduct a conference call and webcast to review its results the following day, Tuesday, December 1, 2020 at 8:00 am ET. To access the call, please dial 1-877-407-9716 or 1-201-493-6779 and provide conference ID 13713475. A live webcast of the conference call can be accessed via the Events and Presentations section of the Field Trip Health Investor Relations website or via the following link: http://public.viavid.com/index.php?id=142525.

For those unable to attend the live call, a telephonic replay will be available until December 15, 2020. To access the replay of the call dial 1-844-512-2921 or 1-412-317-6671 and provide conference ID 13713475. An archived copy of the webcast will be available on the Events and Presentations section of the Field Trip Health Investor Relations website after the conclusion of the call.


About Field Trip Health Ltd.

Field Trip is the global leader in the development and delivery of psychedelic therapies. With our Field Trip Discovery division leading the development of the next generation of psychedelic molecules and conducting advanced research on plant-based psychedelics including psilocybin-producing fungi and our Field Trip Health division building centers for psychedelic therapies opening across North America and Europe along with the digital and technological tools that will enable massive scale, we help people from those in treatment to those seeking accelerated personal growth, with a simple, evidence-based way to heal and heighten engagement with the world.

Learn more at https://www.fieldtriphealth.nl, https://www.fieldtriphealth.com and https://www.meetfieldtrip.com.

Follow us on Twitter and Instagram: @fieldtriphealth

People interested in learning more about Field Trip Health’s Netherlands location and its truffle programs can do so by email ([email protected]) or online at www.fieldtriphealth.nl.

To receive company updates about Field Trip and to be added to the email distribution list please sign up here.

For further information, contact Ronan Levy, Executive Chairman and a Director at Field Trip, at 1 (833) 833-1967.


Cautionary Note Regarding Forward-Looking Information.


This release includes forward-looking information within the meaning of Canadian securities laws regarding Field Trip and its business, which may include, but are not limited to, statements with respect to the listing of the common shares of Field Trip on the Canadian Securities Exchange, and the timing of such events. Often but not always, forward-looking information can be identified by the use of words such as “expect”, “intends”, “anticipated”, “believes” or variations (including negative variations) of such words and phrases, or state that certain actions, events or results “may”, “could”, “would” or “will” be taken, occur or be achieved. Such statements are based on the current expectations and views of future events of the management of Field Trip, and are based on assumptions and subject to risks and uncertainties. Although the management of Field Trip believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release may not occur and could differ materially as a result of known and unknown risk factors and uncertainties affecting the companies, including risks regarding the COVID-19 epidemic, the medical clinic industry, market conditions, economic factors, management’s ability to manage and to operate the business and the equity markets generally. Although Field Trip has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Accordingly, readers should not place undue reliance on any forward-looking statements or information. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and Field Trip does not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.

The CSE has neither approved nor disapproved the contents of this news release.

Media contacts:

Paige Tatulli
Autumn Communications
212-206-9780
[email protected] / [email protected]

Investor contacts:

Elizabeth Barker
KCSA Strategic Communications
212-896-1203
[email protected]

SOURCE Field Trip Health Ltd.



GameStop partners with Sezzle to offer its top-rated Buy Now, Pay Later option online and in-store

PR Newswire

MINNEAPOLIS, Nov. 25, 2020 /PRNewswire/ — Sezzle Inc. (ASX: SZL), the highest-rated Buy Now, Pay Later solution, today announced its partnership with GameStop to provide the world’s largest retailer of video games access to its flexible and innovative digital payment solution. Sezzle is now available at GameStop’s more than 3,300 U.S. retail stores, online at www.gamestop.com, and in the GameStop mobile app.

The partnership comes just in time for millions of shoppers to use Sezzle’s convenient and interest-free payment option when they take advantage of GameStop’s Black Friday and holiday deals. As stricter lockdowns affect much of the country during the holiday season, consumers are shopping for games and relying more than ever on electronics, media, gaming, and interactive activities for entertainment, distraction, and fun.

“We recognize the continued growth of the gaming community and its influence on today’s culture,” said Sezzle President, Paul Paradis. “With its interest-free, pay-in-four option, Sezzle provides an easy, transparent payment and budgeting tool that is a big hit among younger generations. Sezzle is thrilled to offer GameStop’s buyers a safe, financially responsible way to build good credit as they spend this holiday. As a Public Benefit Corp, we hold ourselves accountable to serving our community and financially empowering all of our users, which now includes GameStop shoppers.”

GameStop joins Sezzle’s community of over 20,000 retailers.


About GameStop

GameStop Corp., a Fortune 500 company headquartered in Grapevine, Texas, is the world’s largest omni-channel video game retailer, operates over 5,000 stores across 10 countries, and offers the best selection of new and pre-owned video gaming consoles, accessories and video game titles, in both physical and digital formats. GameStop also offers fans a wide variety of POP! vinyl figures, collectibles, board games and more. Through GameStop’s unique buy-sell-trade program, gamers can trade in video game consoles, games, and accessories, as well as consumer electronics for cash or in-store credit. The company’s consumer product network also includes www.gamestop.com and Game Informer® magazine, the world’s leading print and digital video game publication. General information about GameStop Corp. can be obtained at the Company’s corporate website. Follow @GameStop and @GameStopCorp on Twitter and Instagram and find GameStop on Facebook at www.facebook.com/GameStop.


About Sezzle Inc.

Sezzle is a rapidly growing fintech company on a mission to financially empower the next generation. Sezzle’s payment platform increases the purchasing power for millions of consumers across the U.S. and Canada by offering interest-free installment plans at both online and physical stores. Sezzle’s transparent payment option allows consumers to take control over their spending, be more responsible, and gain access to financial freedom.

This increase in purchasing power for consumers leads to increased sales and basket sizes for the more than 20,000 Merchants that offer Sezzle in the U.S. and Canada.

For more information visit sezzle.com.

Follow Sezzle on social media: LinkedIn | Instagram | FacebookTwitter 

 

 

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/gamestop-partners-with-sezzle-to-offer-its-top-rated-buy-now-pay-later-option-online-and-in-store-301180361.html

SOURCE Sezzle

SNC-Lavalin awarded $38M USD traffic operations management services contract by North Carolina Department of Transportation

Canada NewsWire

MONTREAL, Nov. 25, 2020 /CNW Telbec/ – SNC-Lavalin (TSX: SNC) was selected as prime consultant under a not-to-exceed $38 million USD, three-year limited services contract with two one-year optional extensions to provide traffic operations management support to the North Carolina Department of Transportation’s (NCDOT) Transportation Systems Management & Operations Unit. The contract will be delivered by SNC-Lavalin’s Engineering, Design and Project Management business (EDPM).

“Our North American business has enjoyed a number of significant contract wins this year which cement our position as an established player in a region rich with growth opportunities,” said Philip Hoare, President of Atkins, SNC-Lavalin’s EDPM business. “We now look forward to supporting NCDOT as it continues to deliver critical infrastructure for the state of North Carolina.”

Under the contract, the Company will staff, operate and manage statewide and regional traffic and toll operations centers. In addition, the team will provide project technical support staff to enable a variety of management, administration and traffic engineering functions in support of the operations.

For nearly three decades, the Company has worked with NCDOT in areas ranging from transportation management center (TMC) operations, 511 traffic information line support, intelligent transportation systems and traffic engineering consulting, and toll system design and operations.

“We remain committed to this partnership of collaboration, dedicated to TMC operations for NCDOT and to providing direct support that has spanned cycles of rapid growth, unanticipated contraction, and extreme impacts of natural disasters,” said George Nash, CEO, Atkins North America. “Aligning with NCDOT’s operational goals through changing times, we have and will continue to put the needs of the operations first.”

In the US, SNC-Lavalin’s EDPM business has more than 30 years of TMC operations experience, managing and staffing operations for North Carolina, Georgia, Michigan, Florida and Wisconsin DOTs.


About SNC-Lavalin


Founded in 1911, SNC-Lavalin is a fully integrated professional services and project management company with offices around the world. SNC-Lavalin connects people, technology and data to help shape and deliver world-leading concepts and projects, while offering comprehensive innovative solutions across the asset lifecycle. Our expertise is wide-ranging — consulting & advisory, intelligent networks & cybersecurity, design & engineering, procurement, project & construction management, operations & maintenance, decommissioning and sustaining capital – and delivered to clients in four strategic sectors: EDPM (engineering, design and project management), Infrastructure, Nuclear and Resources, supported by Capital. People. Drive. Results.

www.snclavalin.com

SOURCE SNC-Lavalin

Jacobs Teams with Biomimicry 3.8 to Deliver Sustainable Designs with Nature in Mind

Helping clients achieve next-level sustainability performance inspired by natural systems

PR Newswire

DALLAS, Nov. 25, 2020 /PRNewswire/ — Jacobs (NYSE:J) has signed a strategic alliance teaming agreement with Biomimicry 3.8 (B3.8), a global consulting and innovation firm specializing in nature-based solutions and nature-inspired designs. Biomimicry is an innovation methodology informed by 3.8 billion years of natural evolution and provides a unique platform for the development of sustainable and regenerative designs. 

In response to increasing worldwide needs and client demands for greater positive development impacts, Jacobs has created a unique collaboration with B3.8 to offer Positive Performance, an assessment and innovation methodology created by B3.8 to help corporate clients develop and integrate regenerative best practices, thereby improving the health and wellbeing of ecosystems and the communities who depend on them.

This methodology helps engineers, architects, landscape architects and planners to understand, emulate and facilitate ecosystem services – the multi-faceted benefits that natural ecosystems provide to humanity (such as air quality, carbon sequestration, water cycle management, aesthetics, and renewable energy), in order to deliver health and wellness benefits through their designs.

“The natural world offers us an endless source of inspiring and novel ways to reimagine how we solve pressing challenges to help our clients achieve next-level sustainability performance,” said Jacobs People & Places Solutions Global Market Leader for the Built Environment Monte Wilson. “We have to learn to think differently to solve the complex problems we increasingly face globally, and this agreement with B3.8 reflects Jacobs’ commitment to sustainability and innovation in our cities and communities around the world.”

Jacobs and B3.8 are now engaged on projects with Ford Motor Company and University of California at Davis Healthcare.  

Janine Benyus, B3.8 co-founder and Time Magazine’s Hero for the Planet Award winner, said “Delivering on this level of sustainability vision requires bold partnerships, which is why it’s so exciting to see B3.8 ‘s first-to-market Positive Performance methodology paired with Jacobs’ first-in-class implementation.”

At Jacobs, we’re challenging today to reinvent tomorrow by solving the world’s most critical problems for thriving cities, resilient environments, mission-critical outcomes, operational advancement, scientific discovery and cutting-edge manufacturing, turning abstract ideas into realities that transform the world for good. With approximately $14 billion in revenue and a talent force of more than 55,000, Jacobs provides a full spectrum of professional services including consulting, technical, scientific and project delivery for the government and private sector. Visit jacobs.com and connect with Jacobs on Facebook, InstagramLinkedIn and Twitter.

Certain statements contained in this press release constitute forward-looking statements as such term is defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such statements are intended to be covered by the safe harbor provided by the same. Statements made in this release that are not based on historical fact are forward-looking statements. We base these forward-looking statements on management’s current estimates and expectations as well as currently available competitive, financial and economic data. Forward-looking statements, however, are inherently uncertain. There are a variety of factors that could cause business results to differ materially from our forward-looking statements, including, but not limited to, the impact of the COVID-19 pandemic and the related reaction of governments on global and regional market conditions and the company’s business. For a description of some additional factors that may occur that could cause actual results to differ from our forward-looking statements, see our Annual Report on Form 10-K for the year ended October 2, 2020, and in particular the discussions contained under Item 1 – Business; Item 1A – Risk Factors; Item 3 – Legal Proceedings; and Item 7 – Management’s Discussion and Analysis of Financial Condition and Results of Operations, as well as the company’s other filings with the Securities and Exchange Commission. The company is not under any duty to update any of the forward-looking statements after the date of this press release to conform to actual results, except as required by applicable law.

For press/media inquiries:
Kerrie Sparks
214.583.8433

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/jacobs-teams-with-biomimicry-3-8-to-deliver-sustainable-designs-with-nature-in-mind-301179844.html

SOURCE Jacobs

BioNTech and InstaDeep Announce Strategic Collaboration and Form AI Innovation Lab to Develop Novel Immunotherapies

  • Long-term collaboration underpins BioNTech’s strategy to leverage Artificial Intelligence (AI) and Machine Learning (ML) technologies to support the discovery and development of novel immunotherapies based on InstaDeep’s DeepChain

    TM

    technology platform
  • BioNTech and InstaDeep to establish a joint AI Innovation Lab to advance a portfolio of enterprise-wide digital initiatives in the areas of drug discovery and design, protein engineering, and operations

MAINZ, Germany and LONDON, United Kingdom, November 25, 2020 (GLOBE NEWSWIRE)BioNTech SE (Nasdaq: BNTX, “BioNTech”) and InstaDeep Ltd today announced a multi-year strategic collaboration aimed at applying the latest advances in artificial intelligence (AI) and machine learning (ML) technology to develop novel immunotherapies for a range of cancers and infectious diseases.

As part of the collaboration, BioNTech and InstaDeep will form a joint AI Innovation Lab in London, UK, and Mainz, Germany, to advance a portfolio of initiatives across drug discovery and design, protein engineering, manufacturing and supply chain optimization. The AI Innovation Lab will combine InstaDeep’s advanced capabilities in the areas of artificial intelligence, machine learning, and digitalization along with BioNTech’s deep domain expertise in precision immunotherapies and its access to a wide variety of internal and external datasets. One of the key research areas of the BioNTech-InstaDeep joint Innovation Lab will be the development of next generation vaccines and biopharmaceuticals for the treatment of cancer and prevention and therapy of infectious diseases, including Covid-19.

The strategic collaboration will focus on three core areas:

  • Novel Drug Design: BioNTech is advancing a pipeline of novel mRNA-based vaccines and therapeutics and will apply InstaDeep’s DeepChainTM protein design platform to engineer new mRNA sequences for protein targets, including for its RiboMabTM and RiboCytokineTM platforms, which use messenger RNA to encode antibodies and cytokines in vivo.
  • Advanced Analytics: BioNTech and InstaDeep plan to generate insights from public and proprietary meta datasets, as well as anonymized patient data through the use of machine learning and edge analytics to identify novel biological targets and predictive biomarkers.
  • Manufacturing and Supply Chain Optimization: BioNTech plans to utilize AI and ML applications to further optimize manufacturing and supply chain processes. By employing the latest advances in robotics and autonomous decision-making algorithms, BioNTech aims to deliver higher efficiencies in drug manufacturing, logistics and supply chain processes.

“We see a significant opportunity at the intersection of AI and immunology by computational design of new precision immunotherapies. This collaboration will expand our digital capabilities and optimize our operations across the value chain by adding InstaDeep’s powerful Artificial Intelligence and Machine Learning expertise.  We look forward to working with InstaDeep to advance the next wave of innovation in the field,” says Ugur Sahin, M.D., CEO and Co-Founder of BioNTech.

“Pairing BioNTech’s deep knowledge of the human immune system and scientific data-driven development approach with our AI platform could transform the way we discover and develop new drug classes for patients all over the world. For InstaDeep, the long-term collaboration with BioNTech also means we can further expand on our mission as a company to accelerate the transition to an AI-First world that benefits everyone. Based on the results already achieved by working together, we see an exciting path forward,” says Karim Beguir, Co-Founder and CEO of InstaDeep.

The long-term collaboration builds on the existing relationship between InstaDeep and BioNTech which was initiated in 2019. InstaDeep is headquartered in London and was recently nominated by CB Insights as one of the 100 most promising AI start-ups in the world.

About BioNTech

Biopharmaceutical New Technologies is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. The Company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Its broad portfolio of oncology product candidates includes individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor T cells, bi-specific checkpoint immuno-modulators, targeted cancer antibodies and small molecules. Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline. BioNTech has established a broad set of relationships with multiple global pharmaceutical collaborators, including Genmab, Sanofi, Bayer Animal Health, Genentech, a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit www.BioNTech.de.

About InstaDeep

Founded in 2014, InstaDeep is today an EMEA leader in decision-making AI products for the Enterprise, with headquarters in London, and offices in Paris, Tunis, Lagos, Dubai and Cape Town. With expertise in both machine intelligence research and concrete business deployments, the Company provides a competitive advantage to its partners in an AI-first world. Leveraging its extensive know-how in GPU-accelerated computing, deep learning and reinforcement learning, InstaDeep has built products, such as its novel DeepChainTM protein design platform, that tackle the most complex challenges across a range of industries. InstaDeep has also developed collaborations with global leaders in the Artificial intelligence ecosystem, such as Google DeepMind, Nvidia and Intel. The Company is part of Intel’s AI Builders program and was named a Preferred Deep Learning Partner by Nvidia. To learn more, please visit www.instadeep.com.

BioNTech Forward-looking Statements

This press release contains “forward-looking statements” of BioNTech within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may include, but may not be limited to, statements concerning: the strategic collaboration between BioNTech and InstaDeep; the ability of DeepChain™ protein design platform to engineer new mRNA sequences for protein targets; the ability of AI and Machine Learning to advance drug discovery and development of new drug classes; the ability of AI and Machine Learning to quicken and scale up the delivery of next generation of diagnostics and therapeutics; the ability of Machine Learning and edge analytics to identify novel predictive biomarkers, inform patient selection, and accelerate the development of therapeutic programs; the ability to utilize AI and Machine Learning applications to further optimize manufacturing and supply chain processes, including by using robotics and autonomous decision-making; and BioNTech’s efforts to combat COVID-19. Any forward-looking statements in this press release are based on BioNTech current expectations and beliefs of future events, and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, the ability of AI and Machine Learning to produce improvements in the drug discovery and development process or deliver efficiencies in drug manufacturing, logistics and supply chain. For a discussion of these and other risks and uncertainties, see BioNTech’s Quarterly Report for the Three and Nine Months Ended September 30, 2020, filed as Exhibit 99.2 to its Current Report on Form 6-K filed with the SEC on November 10, which is available on the SEC’s website at www.sec.gov. All information in this press release is as of the date of the release, and BioNTech undertakes no duty to update this information unless required by law.

BioNTech Contacts

Media Relations

Jasmina Alatovic
+49 (0)6131 9084 1513 or +49 (0)151 1978 1385
[email protected]

Investor Relations

Sylke Maas, Ph.D.
+49 (0)6131 9084 1074
[email protected]

InstaDeep Contacts:

Media Relations

Celine Normann
+44 (0)20 3890 7519
[email protected]

Investor Relations

Laurent Hiller
+33 (0)6 22 91 94 71
l.hiller@instadeep

 



Transportation Habits are Changing: New Kia Canada study reveals Canadians’ shifting mindset amid COVID-19 Pandemic

  • Nearly 80% of Canadians feel safest travelling by car
  • 51% of Canadians intend to or would consider purchasing and EV to reduce their carbon footprint
  • Common EV misconceptions revealed

MISSISSAUGA, Ontario, Nov. 25, 2020 (GLOBE NEWSWIRE) —  COVID-19 lockdowns have disrupted what was once considered ‘normal,’ challenging Canadians to adjust their daily lives, rethink travel, and reconsider how to make a positive environmental difference. To determine Canadians’ electric intrigue, Kia Canada commissioned Canadian pollster Angus Reid1 to conduct a recent survey to gauge transportation habits, EV knowledge and misconceptions to help educate consumers on how easy making the switch to EV can be.

The findings show that since the pandemic began, 79% of Canadians say they feel safest travelling by car and 38% are more conscious of their life choices and impact on the environment. In fact, over half the population say they intend to or would consider purchasing an EV for their next vehicle to reduce their carbon footprint.

Collective Green Consciousness

Consumer appetite for sustainable living is growing in popularity and since 2015, Kia Canada has placed over 8,000 EV vehicles on the road and has recorded triple digit year-over-year increases in the past 3 years, showing that many Canadians are increasingly more aware of their environmental choices and looking to engage in green consumerism to better the planet. However, survey findings reveal that 82% of Canadians have never driven an EV before. To understand why this could be, Kia identified common misconceptions that act as EV barriers to help arm Canadians with the facts they need to gain EV confidence.

Tune-Up on EV Facts and Common Misconceptions

The national survey revealed that when it comes to EVs, Canadians were hesitant to make the switch due to four key concerns: charging station availability, the time it takes to charge, vehicle range and the higher cost of EVs.

A strong believer in consumer education, Kia Canada, which offers the largest green car line-up among mainstream automotive manufacturers, understands that EV education comes with experience and is determined to clear up Canadians’ myths and misconceptions about going the distance safely, economically and environmentally in a clean-driving EV.

Myth #1: EV Charging Station Availability
Every day brings new adventure with multiple pitstops along the way. From running daily errands to dropping the kids off at school or hockey practice, Canadians rely on their vehicles to support their busy schedules, no problem.

Here’s where the myth about recharging comes in: 47% of Canadians say they would not consider purchasing an EV and among this group 50% believe finding a charging station is a nuisance, and 30% don’t think they can install a charging port in their home.

And here’s where fact versus fiction comes into play: ChargeHub, Canada’s leading charging station app, says there are more than 14,000 public charging ports (Level 2 and 3) available across Canada, making it easy for drivers everywhere to access charging on-demand – whether its at their local grocery store, service station, or restaurant. In fact, there has been a 50% year-over-year growth in the amount of new charging stations available across the country increasing accessibility for EV drivers2.

To Canadians’ surprise, EV charging is done at home 71% of the time3. Kia supplies a Level 1 charger with the purchase of its Soul EV, Niro EV and Niro PHEV models, providing Canadians the option and safeguard to charge up without having to leave their home.

Myth #2: EV Charge Time

Sixty-eight per cent of Canadian car owners say they drive less than 50kms on an average day, making EVs a realistic and sustainable option to support their daily lifestyles. Offering up to 385km in one single charge, Kia’s popular EV models can support the average driver for up to a week and eliminate the need to stop for fuel or gas along the way. Homeowners who opt for easy home charging installation can also rest easy knowing they can simply plug-in at home, charge overnight, wake-up and go on a full charge.

In the case that drivers need to recharge while en route, all Kia EVs can be recharged to 80% in under an hour using a Level 3 charging station (100kWh). This means you can recharge during a shopping trip or while grabbing lunch, and get back on the road in no time.

Myth 3: EV Range

COVID-19 international border closures have opened our eyes to domestic travel in Canada – with our great nation viewed as THE must-see destination. In fact:

  • 66% of car owners say they use their vehicles for road trips near and far;
  • 47% of Canadians are interested in travelling in their home provinces and 33% are interested in travelling within Canada in the next six months

Longer trips see many Canadians worried about EV range, and don’t think they can go the distance:

  • 84% of Canadians do not know that many EVs can travel more than 350km in a single charge

In reality, Canadians will be thrilled to know that Kia EVs boast an impressive vehicle range (up to 385km on a single charge), matched with dynamic smooth-power performance, and deliver an exciting, efficient drive.

For Canadians who want to go EV, but crave even more range, Kia’s Niro hybrid (HEV) or plug-in hybrid (PHEV) models offer the improved environmental benefits, with a gas engine option for extended trips outside of the city. The best of both worlds!

Myth #4: EV Cost

Every vehicle purchase comes with its own financial commitment. The survey reports that among the 47% of Canadians who would not consider an EV, 59% believe that EVs are too expensive and costly to maintain.

The switch from a gasoline-powered vehicle to an EV is not as costly as one would think and can help Canadians save money throughout the year factoring in the low cost of electricity compared to gas and fewer maintenance costs. In addition to this benefit, the Government of Canada offers federal sales incentives of up to $5,000 to Canadians who purchase zero-emissions vehicles (ZEVs) and provinces, such as British Columbia and Quebec offer up to an additional $3,000 and $8,000 respectively. It’s the perfect time for Canadians to go electric to support a sustainable lifestyle. Your wallet and the environment will thank you.

It’s Time to Go EV

For the majority of Canadians who have never driven an EV, Kia Canada is here to help consumers understand the real-life benefits of electric driving and to showcase the easy switch to EV.

From daily life to long distance drives, Kia EV’s are here to help Canadians go the distance with the Power to Surprise. For more education about Kia’s EV options, cost calculator and government rebate qualifications, visit kia.ca/greencars.

About Kia Canada

Kia Canada Inc. (KCI), founded in 1999 and is a subsidiary of the Kia Motors Corporation (KMC) based in Seoul, South Korea. The full line of award-winning Kia vehicles offers world-class quality and customer satisfaction through a network of 195 dealers across the country. The company employs 170 people at its headquarters in Mississauga, Ontario, as well as in locations across Canada and at its regional office in Montréal, Québec. Kia’s slogan “The Power to Surprise,” symbolizes the company’s worldwide commitment to exceed customer expectations through sustained automotive innovation.

Whether it is a compact, crossover, or electric model which is among the best in the industry, each Kia vehicle offers a superior combination of precision engineering, exceptional performance, innovative features and advanced safety systems. Kia has sold a million vehicles, including popular models in Canada like the Soul, Forte, Sportage, Sorento, Stinger and has recently added the Seltos and K5 to its lineup. To learn more, visit kia.ca or Facebook, LinkedIn, Twitter and Instagram.

Sources

1 From September 23-24, 2020 Angus Reid conducted an omnibus survey among 1,500 Canadians ages 18+. The margin of error—which measures sampling variability—is +/- 2.52%, 19 times out of 20. 

2 Recharge at home in Canada – Geotab Charge The North Report

3 Why Dealers Need to Watch New EV Charging Sites – Canadian Auto Dealer

Please contact Jennifer Nagy or Frédéric Tremblay for more information.

Jennifer Nagy
Strategic Objectives
[email protected]
T 437 215 5378

Frédéric Tremblay
Directeur relations publiques et marketing de détail – Région de l’est
Kia Canada
[email protected]
T 514 955-0505, poste 2209

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/07785684-7faa-4a00-a5f7-e1ef18e1956a



Tauriga Sciences, Inc. Officially Transitions its E-Commerce Payment Processing to Square Inc. & is Now Approved to Accept American Express Credit Cards

The Company’s E-Commerce Platform No Longer has Any Individual Transaction ($) Dollar Limit Imposed

NEW YORK, NY, Nov. 25, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement” chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as two ongoing Biotechnology initiatives, today announced the official transition of its E-Commerce payment processing to Square Inc. (“Square”).  From now on, the Company’s E-Commerce platform no longer has type of individual transaction ($) limit imposed (previously it had been set at $3,000).  The Company is also pleased to disclose that its E-Commerce website (www.taurigum.com) is now approved to accept American Express credit cards for online payments (previously this was limited to: Visa and Mastercard).

ABOUT TAURIGA SCIENCES INC.

Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives.  The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market segment.  The main product line, branded as Tauri-Gum™, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant) & (Vitamin C + Zinc “Immune Booster” Tauri-Gum™ Flavor: Pear Bellini).  The Company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at http://www.tauriga.com.

Complementary to the Company’s retail business, are its two ongoing biotechnology initiatives.  The first one relates to the development of a Pharmaceutical grade version of Tauri-Gum™, for nausea regulation (specifically designed to help patients that are subjected to ongoing chemotherapy treatment). On March 18, 2020, the Company announced that it filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum™.  The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”. The second one relates to a collaboration agreement with Aegea Biotechnologies Inc. for the co-development of a rapid, multiplexed, Novel Coronavirus (COVID-19) test with superior sensitivity and selectivity.   

On October 6, 2020, the Company announced that it has been approved to operate as a U.S. Government Vendor (CAGE CODE # 8QXV4).

On October 7, 2020 the Company disclosed a Strategic Alliance with Think BIG, LLC, Social Impact Startup Founded by CJ Wallace, Son of Christopher “The Notorious B.I.G.” Wallace.

The Company is headquartered in New York City and operates a regional office in Barcelona, Spain.  In addition, the Company operates a full time E-Commerce fulfillment center located in LaGrangeville, New York.

DISCLAIMER — Forward-Looking Statements

This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in  forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.

Contact:

Tauriga Sciences, Inc.
555 Madison Avenue, 5th Floor
New York, NY  10022
Chief Executive Officer
Mr. Seth M. Shaw
Email:  [email protected]
cell # (917) 796 9926
Instagram: @taurigum
Twitter: @SethMShaw
Corp. Website:   www.tauriga.com
E-Commerce Website:  www.taurigum.com

Attachment